Improving Gene Therapy for Duchenne Muscular Dystrophy
Project 1 - Sweeney_Hammers
This project aims to make gene therapies for Duchenne muscular dystrophy safer and more effective for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project ID | NIH-11130232 on NIH RePORTER |
What this research studies
Duchenne muscular dystrophy (DMD) is a serious condition, and while gene therapies are being developed, they still face challenges with safety and effectiveness. Current gene therapies that deliver a modified dystrophin gene can sometimes cause severe immune reactions or heart problems. Our goal is to create new gene therapy designs that are less likely to trigger these harmful responses. We are working on new gene versions and better ways to deliver them to reduce side effects and improve patient outcomes.
Who could benefit from this research
Good fit: This research is relevant for patients living with Duchenne muscular dystrophy who may be candidates for future gene therapy treatments.
Not a fit: Patients without Duchenne muscular dystrophy would not directly benefit from this specific gene therapy development.
Why it matters
Potential benefit: If successful, this work could lead to gene therapies for Duchenne muscular dystrophy that are safer, more effective, and more widely available.
How similar studies have performed: While AAV gene therapies for DMD are already in clinical use, this project focuses on novel improvements to address existing safety and efficacy challenges.
Where this research is happening
Gainesville, United States
- University of Florida — Gainesville, United States (Active)
Researchers
- Principal investigator: Sweeney, H Lee — University of Florida
- Study coordinator: Sweeney, H Lee
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.